These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2046275)

  • 21. Dyslipidemia in pediatric nephrotic syndrome: causes revisited.
    Delvin EE; Merouani A; Levy E
    Clin Biochem; 2003 Mar; 36(2):95-101. PubMed ID: 12633757
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical anomalies of the nephrotic syndrome.
    Lewith G; Gabriel R
    Curr Med Res Opin; 1975; 3(4):199-202. PubMed ID: 168035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of nephrotic hyperlipidemia with lovastatin.
    Elisaf M; Dardamanis M; Pappas M; Sferopoulos G; Siamopoulos KC
    Clin Nephrol; 1991 Jul; 36(1):50-2. PubMed ID: 1889153
    [No Abstract]   [Full Text] [Related]  

  • 25. The hyperlipidemia of the nephrotic syndrome.
    Appel GB; Valeri A; Appel AS; Blum C
    Am J Med; 1989 Nov; 87(5N):45N-50N. PubMed ID: 2486547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention and management of complications in nephrotic syndrome].
    Mitarai T
    Nihon Rinsho; 2004 Oct; 62(10):1893-7. PubMed ID: 15500136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disorders of lipid metabolism in patients with nephrotic syndrome].
    Zdrojewski Z
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):696-9. PubMed ID: 1492041
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cause of hyperlipemia in nephrotic syndrome].
    Yoshitoshi Y; Naito C
    Nihon Rinsho; 1968 May; 26(5):1106-16. PubMed ID: 4883020
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood lipid disorders in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects].
    Campanacci L
    Minerva Med; 1976 Sep; 67(46):2951-60. PubMed ID: 787832
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nephrotic syndrome: etiology, pathogenesis, clinical course].
    Tareeva IE; Poliantseva LR; Kutyrina IM
    Klin Med (Mosk); 1993 Jan; 71(1):47-51. PubMed ID: 8046908
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipid metabolism in kidney diseases].
    Yoshitoshi Y; Naito C
    Naika; 1968 Oct; 22(4):824-30. PubMed ID: 4884620
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid abnormalities in progressive renal insufficiency.
    Attman PO; Samuelsson O; Alaupovic P
    Contrib Nephrol; 1997; 120():1-10. PubMed ID: 9257042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some aspects of hyperlipemia in the nephrotic syndrome].
    Guarini G; Costa C; Leri O; Cerulli C
    Minerva Nefrol; 1975; 22(1):54-7. PubMed ID: 1207973
    [No Abstract]   [Full Text] [Related]  

  • 34. The hyperlipidemia of the nephrotic syndrome.
    Black RM
    N Engl J Med; 1985 Nov; 313(20):1298-9. PubMed ID: 4058520
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment.
    Wheeler DC; Bernard DB
    Am J Kidney Dis; 1994 Mar; 23(3):331-46. PubMed ID: 8128933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperlipidemia in kidney diseases].
    Saito T
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():407-11. PubMed ID: 17824062
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M; Anarat A; Bayazit AK; Noyan A; Ozel A; Anarat R; Aydingülü H; Dikmen N
    Turk J Pediatr; 2002; 44(1):40-4. PubMed ID: 11858378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipoproteinemia in the nephrotic syndrome].
    Yasugi T; Shimizu T; Iijima M; Tomita M; Harada M
    Saishin Igaku; 1972 Mar; 27(3):504-9. PubMed ID: 5021394
    [No Abstract]   [Full Text] [Related]  

  • 39. [Certain indices of lipid metabolism in patients with hemorrhagic fever and renal syndrome].
    Koval'skiĭ GS; Starostina IS
    Klin Med (Mosk); 1973 May; 51(5):41-5. PubMed ID: 4768965
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.